From the start, our MadeTraceable™ mission has been non-negotiable, and our POV clear: Knowing what you’re putting into your body (and why) should be a given, more necessity than a “nice-to-have.”
That said, as skeptics, we don’t just want you to take us at our word—we’re committed to showing you the receipts along the way. One part of that is building a clinical-backed future, which is why our first clinical trial quantifying the impact of Essential for Women 18+ was such a huge deal.
And it paid off: The results from our 12-week clinical trial—conducted as a double-blind, placebo-controlled trial in partnership with Auburn University, on 94 women ages 21 through 40—were significant, with Essential for Women 18+ increasing vitamin D3 levels by 43% and omega-3 DHA levels by 41% in just 12 weeks.*
With that, we’re thrilled to share another huge milestone:
Our gold standard clinical study has been published in Frontiers in Nutrition—a leading, internationally recognized, peer-reviewed journal.
To be clear, having a study published in a peer-reviewed journal is one of the highest awards scientific research can achieve—it means our study was put through the quality control ringer; everything from the design and implementation to the analysis and accuracy of our results was carefully evaluated and accepted by reviewers.